Results 171 to 180 of about 189,595 (350)

Coronary Ectasia and ST Elevation Myocardial Infarction Patients: Does Atherosclerosis Influence Periprocedural Management and Long‐Term Prognosis?

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Coronary artery ectasia (CAE) influences procedural outcomes in the context of ST‐elevation myocardial infarction (STEMI); however, its relationship with atherosclerotic coronary artery disease (ACAD) remains unclear. Aims This study aimed to compare clinical and procedural characteristics, as well as outcomes, in patients with ...
Victorine Fraichot, Jeanne Varlot, Florian Eggenspieler, Nassima Djaballah, Pierre Adrien Metzdorf, Edoardo Camenzind, Batric Popovic   +6 more
wiley   +1 more source

Anterior mediastinal haematoma and left haemothorax on well-controlled oral anticoagulant therapy [PDF]

, 1983
M Abaskaron, Grace Peterson, Tsung-Yao Huang   +2 more
openalex   +1 more source

Micellar Liquid Chromatography Determination of Edoxaban in Oral Solid Dosage Forms: Theoretical Aspects and Validation

ChemMedChem, EarlyView.
A method is developed and validated to quantify edoxaban in solid oral dosage forms using micellar liquid chromatography. A chemometric strategy is used to study the retention mechanism. The procedure is green, economic, safe, and easy to handle; offers high sample throughput; and is reliable, thus useful for pharmaceutical quality control.
Juan Peris‐Vicente, Devasish Bose, Rajendra‐Pasad Pawar, Abhilasha Durgbanshi, Samuel Carda‐Broch   +4 more
wiley   +1 more source

A Modified Quick's One-stage Test for the Control of Out-patients on Anticoagulant Therapy

, 1960
Benjamin Thompson
openalex   +1 more source

Design and Evaluation of Sticky End‐Type Bivalent DNA Aptamers Containing M08s‐1 as Anticoagulant Agents

ChemMedChem, EarlyView.
Sticky end‐type antithrombin aptamer, composed of two short hybridizable segments, is developed as a potential alternative to conventional anticoagulant drugs. The obtained bivalent aptamer surpasses existing long bivalent aptamers in anticoagulant activity and serum stability, offering advantages in synthesis efficiency and cost‐effectiveness. Aptamer
Maasa Yokomori, Mizuki Murasawa, Muneyuki Matsuo, Masanobu Nagano, Keitaro Yoshimoto   +4 more
wiley   +1 more source

Control of Oral Anticoagulant Therapy, with Special Reference to Quick Test and Thrombotest : Symposium on Heart Diseases and Anticoagulants

, 1963
Kiyoto Satake
openalex   +2 more sources

Relative Bioavailability, Food Effect, and Bioequivalence Studies to Assess a New Zanubrutinib 160‐mg Tablet: Results From 2 Phase 1 Studies in Healthy Volunteers

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Zanubrutinib is a next‐generation Bruton tyrosine kinase inhibitor approved for treating B‐cell malignancies. Two phase 1 studies evaluated a new 160‐mg zanubrutinib tablet versus 80‐mg capsules. In study BGB‐3111‐115 (n = 43), a randomized 3‐period crossover trial, relative bioavailability and food effects were assessed.
Bilal Tariq, Chester Lin, Vaibhav Mundra, Yang Gao, Dan Zhang, Ying C. Ou   +5 more
wiley   +1 more source

Gross haematuria in the era of anticoagulant therapy - Implications on treatment and diagnostic approaches in a large emergency department patient population. [PDF]

BJUI Compass
Yang Y, Seidl J, Engelmann SU, Haas M, Mayr R, Burger M, Breyer J, Resch M.   +7 more
europepmc   +1 more source

Studies on the Methods of Control and of Administration of Drugs for Anticoagulant Therapy : Symposium on Heart Diseases and Anticoagulants

, 1963
Manabu D. Yamanaka
openalex   +2 more sources

Prophylactic low dose heparin anticoagulant therapy in patients with spinal cord injuries: a retrospective study [PDF]

, 1992
Jai Kulkarni, A A Burt, A T Tromans, Peter D. Constable   +3 more
openalex   +1 more source